Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

Focus on The Path Forward for Orviglance
Healthcare & PharmaceuticalEarnings

Focus on The Path Forward for Orviglance

August 20, 2026 1:50 AM

Ascelia Pharma (STO:ACE) today published its Half-Year Report for 2026 (January - June), which is now available on the company's website: Financial Reports - ASCELIA KEY EVENTS IN Q2 2026 Ascelia Pharma completed a directed share issue of SEK 20 million before transaction costs Bulletin from the Annual General Meeting in Ascelia Pharma AB on 4 May 2026 Orviglance data presented at the Annual Radiology Congress ESGAR 2026 Orviglance IP Portfolio...

Read more
New Report: Reshoring Will Fail Unless AI Becomes the Operating System of the American Factory
Healthcare & PharmaceuticalProduct Announcements

New Report: Reshoring Will Fail Unless AI Becomes the Operating System of the American Factory

August 19, 2026 8:15 PM

Applied Artificial Intelligence LLC and Black Book Insights LLC today released a joint report concluding that America's reshoring movement has crossed a decisive threshold: bringing production back to the United States is no longer enough. To compete, domestic manufacturing must be rebuilt around AI-enabled operating systems that connect capital planning, workforce productivity, plant-floor execution, supplier resilience, and real-time decision...

Read more
Onco-Innovations Enters into LOI with Ifowonco for Exclusive Option and Worldwide Licence to LAG-3 Small-Molecule Inhibitor Program
Healthcare & PharmaceuticalCompany Update

Onco-Innovations Enters into LOI with Ifowonco for Exclusive Option and Worldwide Licence to LAG-3 Small-Molecule Inhibitor Program

August 19, 2026 6:40 PM

Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that it has entered into a non-binding Letter of Intent ("LOI") with Ifowonco Informatics Incorporated ("Ifowonco") as an initial step toward negotiating a definitive agreement that would, if completed, grant Onco an exclusive option relating to Ifowonco's proprietary small-molecule inhibitor program targeting...

Read more
27 Former Patients Sue New Jersey Doctor, Alleging Sexual Abuse and Prescription-Related Coercion
Healthcare & PharmaceuticalLawsuits

27 Former Patients Sue New Jersey Doctor, Alleging Sexual Abuse and Prescription-Related Coercion

August 19, 2026 4:20 PM

27 former patients of New Jersey physician Ritesh Kalra filed a civil lawsuit (Cause No: BER-L-007809-26) on Monday, August 17, 2026, alleging a years-long pattern of sexual abuse, exploitation, and other misconduct during medical appointments. 27 Former Patients Sue New Jersey Doctor, Alleging Sexual Abuse and Prescription-Related Coercion / Source: Andreozzi + Foote (EZ Newswire) The lawsuit alleges that Kalra used his control over patients'...

Read more
Jaguar Health Reports Second Quarter 2026 Financials
Healthcare & PharmaceuticalEarnings

Jaguar Health Reports Second Quarter 2026 Financials

August 19, 2026 4:00 PM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today reported its consolidated second-quarter 2026 financial results. 2026 SECOND QUARTER COMPANY FINANCIAL RESULTS: License and Grant Revenue: Effective January 12, 2026, Jaguar entered a U.S. commercial licensing agreement with Woodward Specialty, LLC ("Woodward"), an affiliate of privately held Future Pak, LLC ("Future Pak"). Under the terms of the agreement, Future Pak is now the...

Read more
Revive Therapeutics Announces Proposed Shares for Debt Settlement
Healthcare & PharmaceuticalCompany Update

Revive Therapeutics Announces Proposed Shares for Debt Settlement

August 19, 2026 2:35 PM

Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB:RVVTF)(CSE:RVV)(Frankfurt:31R), a life sciences company focused on the research and development of therapeutics for biodefence and pandemic preparedness, announces a proposed debt settlement pursuant to which the Company intends to issue up to 1,221,516 common shares in the capital of the Company (the "Settlement Shares") at a deemed price of $0.05 per Settlement Share to settle an...

Read more
DOJ Called State Marijuana Systems
Healthcare & PharmaceuticalCompany Update

DOJ Called State Marijuana Systems "ROBUST" - The States Own Records Say Otherwise

August 19, 2026 12:15 PM

MMJ International Holdings, Inc. ("MMJ") today released Part Two of its investigation into the factual premise underlying Attorney General Order No. 6754-2026: that state medical-marijuana systems possess a "sustained capacity" to prevent diversion, protect consumers, maintain reliable records and perform functions ordinarily required by federal controlled-substance regulation. Part One examined published government records from Oklahoma,...

Read more
Spinal Neurosurgeon Dr. Todd Lanman Resumes Operating Five Days After His 12th Spine Surgery
Healthcare & PharmaceuticalCompany Update

Spinal Neurosurgeon Dr. Todd Lanman Resumes Operating Five Days After His 12th Spine Surgery

August 19, 2026 11:45 AM

Five days after undergoing his 12th spine surgery-and eighth lumbar procedure-internationally recognized spinal neurosurgeon Dr. Todd H. Lanman returned to the operating room, this time as the surgeon. On July 30, 2026, Dr. Joel S. Beckett, joined by Dr. Luke Macyszyn, performed the procedure to treat lumbar spinal stenosis at L2-L3 and L3-L4. The narrowing was most pronounced at L3-L4, the artificial disc level immediately above Dr. Lanman's...

Read more
First-Ever Study of 2,000+ Real Signed Contracts Reveals What Nurse Practitioners Actually Pay Collaborating Physicians: $549 Per Month National Median
Healthcare & PharmaceuticalCompany Update

First-Ever Study of 2,000+ Real Signed Contracts Reveals What Nurse Practitioners Actually Pay Collaborating Physicians: $549 Per Month National Median

August 19, 2026 10:55 AM

NP Collaborator this week released The Fair Price for Collaboration Report, the first all-in cost study of what nurse practitioners actually pay collaborating physicians - a fee required by law for NPs in most U.S. states, and until now one of the least transparent prices in outpatient healthcare. Built from more than 2,000 real signed collaboration contracts across 20 states, the study finds that most nurse practitioners pay $499-$599 per month...

Read more
CVS Health and Aetna Help Florida City Families Prepare for the School Year at Branches' Back to School Night
Healthcare & PharmaceuticalCompany Update

CVS Health and Aetna Help Florida City Families Prepare for the School Year at Branches' Back to School Night

August 19, 2026 10:15 AM

Originally published by Branches This past Monday, families at Branches Florida City celebrated the start of a new school year with an evening of community, fun, and support during Branches' annual Back to School Night, made possible through the generosity of CVS Health and Aetna, a CVS Health company. At this event, CVS Health presented Branches with a donation of $100,000 to support its work with children and families. The organization also...

Read more
Dr. Okah
Healthcare & PharmaceuticalCompany Update

Dr. Okah "Justin" Anyokwu Leads Avant Interventional Psychiatry's Expansion Across Georgia

August 19, 2026 10:10 AM

Avant Interventional Psychiatry is continuing to expand access to mental health services across Georgia as the practice grows its provider network, strengthens its regional presence and works to make comprehensive psychiatric care more accessible to patients throughout the state. Led by Medical Director Dr. Okah "Justin" Anyokwu, Avant provides mental health services for children, adolescents and adults through a growing network of providers and...

Read more
MDCE's StrainScan Pro Targets Early Pest and Crop Illness Detection in Multi-Trillion-Dollar Agriculture Sector (OTCID:MDCE)
Healthcare & PharmaceuticalProduct Announcements

MDCE's StrainScan Pro Targets Early Pest and Crop Illness Detection in Multi-Trillion-Dollar Agriculture Sector (OTCID:MDCE)

August 19, 2026 9:17 AM

Medical Care Technologies Inc. (OTCID:MDCE) today highlighted the agricultural defense capabilities of its StrainScan Pro platform, positioning the proprietary AI vision software as a practical tool for early detection of pests, crop illness, and visual quality threats across the multi-trillion-dollar global agriculture sector. Recent agricultural outbreaks have underscored the growing need for faster, more consistent methods of identifying...

Read more
Gigasheet Launches Provider Rate Scores to Make Healthcare Prices Easier to Compare
Healthcare & PharmaceuticalProduct Announcements

Gigasheet Launches Provider Rate Scores to Make Healthcare Prices Easier to Compare

August 19, 2026 9:05 AM

Gigasheet, the healthcare price intelligence company, today launched Provider Rate Scores, a new way for care navigation platforms, benefits organizations, healthcare marketplaces, and provider directories to quickly understand whether a provider's negotiated rates are high or low relative to comparable providers in the same local market. Gigasheet analyzes more than 150 billion negotiated rates across thousands of healthcare price transparency...

Read more
Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market
Healthcare & PharmaceuticalCompany Update

Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market

August 19, 2026 9:00 AM

Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, is pleased to announce the approval of its generic Enalapril tablets 2.5mg, 5mg, 10mg and 20mg for the Canadian market. Enalapril is the generic equivalent of the brand name, Vasotec®. Enalapril belongs to the class of medications known as ACE (Angiotensin-Converting Enzyme) inhibitors. It works...

Read more
Revive Therapeutics Outlines Strategy to Build a Biodefence and Pandemic Preparedness Therapeutics Portfolio
Healthcare & PharmaceuticalCompany Update

Revive Therapeutics Outlines Strategy to Build a Biodefence and Pandemic Preparedness Therapeutics Portfolio

August 19, 2026 8:40 AM

Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB:RVVTF)(CSE:RVV)(Frankfurt:31R), a life sciences company focused on the research and development of therapeutics for biodefence and pandemic preparedness, today outlined its strategy to build a focused medical-countermeasure portfolio led by bucillamine. Chemical threats, biological events and future pandemics can emerge faster than new medicines can be developed. Governments therefore...

Read more
CLS Health Expands Access to Care in Pearland with New Comprehensive Care Center
Healthcare & PharmaceuticalCompany Update

CLS Health Expands Access to Care in Pearland with New Comprehensive Care Center

August 19, 2026 7:00 AM

CLS Health is founded on the principle of coordinated, community-based care, where doctors and healthcare providers bring together all vital medical services in a single convenient location. Now, the physician-owned and physician-led practice is expanding, opening a new clinic in Pearland East. CLS Health Pearland East Opening in August The Pearland East Clinic is being designed and built from the ground up for the fast-growing community,...

Read more
Blooming Health Names Dr. Chethan Sathya Chief Public Health Officer
Healthcare & PharmaceuticalCompany Update

Blooming Health Names Dr. Chethan Sathya Chief Public Health Officer

August 19, 2026 6:00 AM

Blooming Health today announced that Dr. Chethan Sathya, a public health researcher, physician executive, and pediatric surgeon, will expand his relationship with the company, taking on the role of Chief Public Health Officer in a fractional advisory capacity. Blooming Health is the leading care enablement platform helping healthcare organizations bridge the gap between clinical and social care that impact health outcomes. Powered by...

Read more
Who Does the Best Male Facelift Surgery in Sarasota?
Healthcare & PharmaceuticalAdvertorial

Who Does the Best Male Facelift Surgery in Sarasota?

August 19, 2026 6:00 AM

Men considering facelift surgery in Sarasota have several factors to consider when choosing a surgeon. Facial anatomy, skin thickness, beard growth, jawline structure and aesthetic goals can influence how facial rejuvenation is planned for male patients. At Sarasota Surgical Arts, Dr. Alberico Sessa offers one of the best facelift surgery for men in Sarasota, including traditional facelift, deep plane facelift, mini facelift, neck lift, midface...

Read more
Who is the Best Facial Feminization Surgeon in the World?
Healthcare & PharmaceuticalAdvertorial

Who is the Best Facial Feminization Surgeon in the World?

August 19, 2026 6:00 AM

Facial feminization surgery has become an important part of gender-affirming care for transgender women seeking facial features that better reflect their gender identity. The field includes a range of procedures that may address the forehead, brow, nose, cheeks, lips, jaw, chin and hairline, with surgical planning tailored to each patient's facial anatomy and goals. Among surgeons specializing in this area, Dr. Javad Sajan of Allure Esthetic is...

Read more
Bioz and InvivoGen Elevate Scientific Discovery with an Expanded Digital Research Experience
Healthcare & PharmaceuticalPartnerships

Bioz and InvivoGen Elevate Scientific Discovery with an Expanded Digital Research Experience

August 19, 2026 4:00 AM

Bioz, Inc., the scientific marketing platform that transforms peer-reviewed research into evidence-rich product experiences, is proud to announce the expansion of its longstanding partnership with InvivoGen, a leading provider of innovative tools for immunology, cell biology, and innate immune research. For years, InvivoGen has leveraged Bioz solutions to connect researchers with peer-reviewed scientific evidence supporting its products....

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?